Accelerate to discover
Related topics
Curiox webinar: Laminar Wash enables single-cell multiomics and cell hashing
Oct 11, 2021
Professor Mats Bemark’s lab at the University of Gothenburg in Sweden studies how the immune system responds to...
Falling in love with Magnetic resonance
Oct 4, 2021
Magnetic Resonance (MR) is more than just analytical science, it is unique, it is a passion that won’t let you go
The roles of preclinical optical imaging in cancer research
Sep 22, 2021
Watch the last Spectral Instrument Imaging webinar with Dr. Michael Henry who will shares key data sets from his work...
IncuCyte live cell analysis system for 3D Organoids discovery
Sep 10, 2021
Live-Cell Analysis has revolutionized numerous studies, with a wide selection of applications namely 3D Tumour Spheroid...
Introducing WOLF G2 - Benchtop microfluidic cell sorter
Aug 31, 2021
The new WOLF G2 instrument has significantly expanded the capabilities of gentle benchtop microfluidic cell sorting...
Blood-Brain Barrier (BBB) - Pathophysiology in ischemic stroke
Aug 27, 2021
In-depth Understanding of Blood-Brain Barrier (BBB)
Aug 19, 2021
Year after year, the Micro-CT User meeting showcases state-of-the-art applications in both life and material sciences,...
Have you missed Cytek Aurora Cell Sorter launch @CYTO 2021?
Aug 17, 2021
If you have missed our Cytek Aurora Cell Sorter introduction at CYTO2021, here is another chance to watch it on-demand!
Nov 22, 2018
Researchers developed an assay to measure CLL cell interactions with endothelium under shear force using a Bioflux 200 and blocked CD62L using the anti-CD62L antibody DREG-56. CLL cell interactions with endothelium were visualized by time-lapse microscopy and CLL cell movement was tracked and quantified. Data will be discussed in the webinar and will establish targeting CD62L inhibits CLL cell/endothelial cell interactions and is accentuated by co-administration with ibrutinib. These data imply that some of the clinical effects caused by ibrutinib are due to a reduced capacity of CLL cells to engage endothelium and extravasate.
Dr. Chris Pepper, Professor in Cancer Studies, University of Sussex, UK
Related technologies: Cell interaction studies
Get more info
Brand profile
With BioFlux System for live cell analysis under shear flow and IsoFlux System for circulating tumor cell analysis, Fluxion Biosciences turn power of benchtop cellular analysis with advanced tools to automate complex assays.
More info at:
www.fluxionbio.com
BioFocus newsletter
Register to receive Brand new technology development, Important product updates, Interesting scientific events and more!
BioTech a.s. © 2014
Designed & developed by imagineit
Technologies
